1. PRLog Home
  2. Business Index
  3. Pressroom Index
  4. Press Releases Home
  1. About
  2. Press Room
  3. Contact
Filter By Industry
Filter By Tag

Press Room

KOGS Communication LLC Press releases

1 - 2 of 2 Press Releases

Dec 16, 2014
Growing body of clinical evidence shows greater tumor penetration, targeted delivery, efficiency and cost savings with the Surefire device

Nov 27, 2012
First human trial for Tay-Sachs, Canavan and other rare enzyme deficiency diseases plans to begin in early 2013 thanks to NTSAD, the nation's oldest patient advocacy organization, which leads efforts to find a cure or treatment.

RSS Feed for KOGS Communication LLC Press Releases